| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3474926 | Italian Journal of Medicine | 2009 | 8 Pages |
Abstract
At the time of FASTCAP, NHAP was included in the category of CAP, and coherently, treatment of NHAP was not more aggressive if compared to community-acquired infections. However, our results confirm that NHAP is at increased risk for worst outcome, and probably worth considering for specific therapeutic strategies. Future studies are needed to better assess the microbiology of NHAP, and to evaluate if specific treatments, as those recommended by recent guidelines, may improve the outcome for these high-risk patients.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Gualberto Gussoni, Ido Iori, Francesco Blasi, Alessandro Bulfoni, Sebastiano Costantino, Massimo Giusti, Antonella Valerio, Delfino Legnani, a nome del Gruppo di Studio FASTCAP a nome del Gruppo di Studio FASTCAP,
